Efficacy of combined thoracic paravertebral block and intravenous dexmedetomidine in medical thoracoscopy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202005777730971

Enrollment

Registered

2020-05-29

Start date

2020-04-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System Respiratory

Interventions

General anaesthesia

Thoracic paravertebral block and IV dexmedetomidine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients indicated for medical thoracoscopy ASA I and II Aged 25-55 years No history of allergy to any of the used drugs.

Exclusion criteria

Exclusion criteria: ASA III and IV Aged below 25 or above 55 years History of allergy to any of the used drugs. Uncooperative patient Severe musculoskeletal abnormalities Patients with coagulopathy

Design outcomes

Primary

Measure	Time frame
Patient rated procedural pain on Visual Analogue Scale	—

Secondary

Measure	Time frame
Heart rate (beats/min), mean arterial blood pressure (mmHg) and SpO2%. ;Operator rated overall procedure satisfaction (quality of the image, ease of maneuvering, ease of obtaining a biopsy sample, and the expectation that the biopsy sample will reveal a definitive histological diagnosis) on the visual analog scale from 0 to 100.	—

Countries

Egypt

Contacts

Public ContactAhmed Abdelhady

Lecturer of Chest diseases Faculty of Medicine Alexandria University

drahmedhady@gmail.com+201227896890

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026